Dasatinib 100 mg once daily minimizes the occurrence of pleural effusion in patients with chronic myeloid leukemia in chronic phase and efficacy is unaffected in patients who develop pleural effusion (Q34289635)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dasatinib 100 mg once daily minimizes the occurrence of pleural effusion in patients with chronic myeloid leukemia in chronic phase and efficacy is unaffected in patients who develop pleural effusion |
scientific article |
Statements
1 reference
Dasatinib 100 mg once daily minimizes the occurrence of pleural effusion in patients with chronic myeloid leukemia in chronic phase and efficacy is unaffected in patients who develop pleural effusion (English)
1 reference
Jorge E Cortes
1 reference
Kimmo Porkka
1 reference
H Jean Khoury
1 reference
Ronald L Paquette
1 reference
Yousif Matloub
1 reference
Ritwik Sinha
1 reference
1 January 2010
1 reference
1 reference
116
1 reference
2
1 reference
377-386
1 reference
Identifiers
1 reference
1 reference
1 reference